Today, the Blue Ribbon Panel of advisers for Vice President Joe Biden’s Cancer Moonshot Initiative presented a set of 10 recommendations for research opportunities worthy of investment. While these recommendations do not cover every corner of cancer research, they provide a framework for building on the progress we’ve made to help more scientists collaborate, make(...)
It seems that more young people in their 30s and 40s are being diagnosed. Are any studies looking at this and can they help younger patients?
Posted by | Research“I'm not aware of data to show that more young people are being diagnosed with lung cancer,” says Russell K. Hales, M.D., a radiation oncologist, at the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “But anecdotally, it is what I seem to be seeing as well. What we tend to see(...)
Stronger Than Colon Cancer
Posted by | Patient StoriesTrina Taylor (Isaac) has felt God’s guidance throughout her journey with colorectal cancer. She had been out of work for over a year before she was hired at The Johns Hopkins Hospital in 2008, an opportunity that was an answer to her prayers and more. Isaac remembers feeling sluggish. Already thin, she was losing more(...)
What Kids Say About Camp
Posted by | Patient Stories***With the end of summer, this concludes our three-part series about Camp Sunrise, a place of summer fun for pediatric oncology patients at the Johns Hopkins Kimmel Cancer Center. Read parts one and two. We asked kids and staff from Camp Sunrise to describe what they love about camp and their dreams for the future. Here's(...)
How do you determine what stage of cancer I have?
Posted by | Prevention/Screening“Staging is a critical part of therapy,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “We don’t want to focus only on a tumor in the chest, for example, if there’s something growing in another area of the body. That’s why we fully(...)
Amanda’s Camp Story
Posted by | Patient Stories***With the end of summer, we bring you a three-part series about Camp Sunrise, a place of summer fun for pediatric oncology patients at the Johns Hopkins Kimmel Cancer Center. This is the second part of the series; read part one. Childhood is supposed to be marked by sweet and simple memories, like losing a(...)
Are there any long term effects or dangers from radiation for lung cancer?
Posted by | Survivorship, treatment“Absolutely, yes. All of our therapies, surgery, radiation, chemotherapy, and targeted therapy for lung cancer come with risks and benefits,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “We use those therapies only after careful evaluation of the risks of the therapy, versus(...)
While pediatric cancer doctors heal the body, Camp Sunrise heals the soul
Posted by | Patient Stories***With the end of summer, we bring you a three-part series about Camp Sunrise, a place of summer fun for pediatric oncology patients at the Johns Hopkins Kimmel Cancer Center. Part two features Amanda's story. What began in 1986 with seven campers has grown into the Kimmel Cancer Center-managed and -operated Camp Sunrise. The camp is(...)
Is it important to watch your vitamin levels during cancer treatment?
Posted by | treatment“Certainly, it’s never optimal to have deficiencies in vitamin levels,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “We try to make sure that our patients are healthy, and taking a multivitamin every day.” However, Hales warns against lung cancer patients taking high(...)
What Makes Some Kidney Cancers Resistant to Immunotherapy?
Posted by | ResearchSuzanne Topalian, M.D., associate director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, is a pioneer in the search for biomarkers that predict responses to immunotherapy. In April at the American Association for Cancer Research meeting in New Orleans, Topalian and her colleagues presented data linking a virus-associated cancer, called Merkel cell carcinoma - to response(...)